The GRACE risk score provides robust, validated risk stratification for patients with acute coronary syndrome, guiding treatment decisions in accordance with major clinical guidelines.
No takes yet. Share an insight, caveat, or question.
May support long-term ACS prognostication; leaves open whether GRACE-guided therapy improves outcomes.
Freek W.A. Verheugt (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: